Signal Transduction and Targeted Therapy (Apr 2023)
Two vs three cycles of neoadjuvant sintilimab plus chemotherapy for resectable non-small-cell lung cancer: neoSCORE trial
Abstract
No abstracts available.
Signal Transduction and Targeted Therapy (Apr 2023)